Manufacturer of Controlled Substances; Notice of Application, 3546 [E6-716]
Download as PDF
<![CDATA[
3546
Federal Register / Vol. 71, No. 14 / Monday, January 23, 2006 / Notices
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than February 22, 2006.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e) and (f) are
satisfied.
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than March 24, 2006.
Dated: January 11, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–716 Filed 1–20–06; 8:45 am]
BILLING CODE 4410–09–P
Dated: January 11, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–718 Filed 1–20–06; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
By Notice dated October 18, 2005, and
published in the Federal Register on
August 19, 2005, (70 FR 48780), Sigma
Aldrich Research Biochemicals, Inc., 1–
3 Strathmore Road, Natick,
Massachusetts 01760, made application
by letter to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of NBenzylpiperazine (7493), a basic class of
controlled substance listed in Schedules
I.
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. § 823(a) and
determined that the registration of
Sigma Aldrich Research, Biochemicals,
Inc. to manufacture the listed basic
classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Sigma
Aldrich Research, Biochemicals, Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on July 12, 2005,
National Center for Natural Products
Research—NIDA MProject, University of
Mississippi, 135 Coy Waller Lab
Complex, University, Mississippi 38577,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
Schedules I:
Drug
Schedule
erjones on PROD1PC61 with NOTICES
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
I
I
The company plans to cultivate
marihuana for the National Institute of
Drug Abuse for research approved by
the Department of Health and Human
Services.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
VerDate Aug<31>2005
13:01 Jan 20, 2006
Jkt 208001
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: January 11, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–715 Filed 1–20–06; 8:45 am]
BILLING CODE 4410–09–P
NATIONAL SCIENCE FOUNDATION
National Science Board; Workshop on
Hurricane Science and Engineering;
Toward A National Agenda for
Hurricane Science and Engineering:
Perspectives From Federal Agencies
Date and Time: January 24, 2005, 8
a.m.–5:15 p.m. (ET).
Place: National Science Foundation,
4201 Wilson Boulevard, Room 1235,
Arlington, VA 22230.
Public Meeting Attendance: All
visitors must report to the NSF’s
visitor’s desk at the 9th and N. Stuart
Streets entrance to receive a visitor’s
badge.
Contact Information: Please refer to
the National Science Board Web site
(https://www.nsf.gov/nsb) for updated
Agenda. NSB Office: (703) 292–7000.
Status: This Workshop will be open to
the public.
Provisional Workshop Agenda
8–8:05 a.m. Welcoming Remarks.
8:05–8:20 a.m Motivation, Purpose
and Goals.
8:20–8:30 a.m. Process and Logistics
for NSB Workshops.
8:30–9:30 a.m. Panel Session I:
Physical, Biological and Ecological
Sciences.
9:30–10 a.m. Roundtable Discussion.
10–10:15 a.m. Break.
10:15–11:15 a.m. Panel Session II:
Social, Behavioral, and Economic
Sciences.
11:15–11:45 a.m. Roundtable
Discussion.
1–2 p.m. Panel Session III: Engineering
and Infrastructure.
2–2:30 p.m. Roundtable Discussion.
2:30–4 p.m. Break-Out Groups (3
concurrent sessions).
4–5 p.m. Break-Out Group Reports and
Discussion.
5–5:15 p.m. Summary and Next Steps.
5:15 p.m. Adjourn.
Michael P. Crosby,
Executive Officer and NSB Office Director.
[FR Doc. E6–711 Filed 1–20–06; 8:45 am]
BILLING CODE 7555–01–P
E:\FR\FM\23JAN1.SGM
23JAN1
]]>Agencies
[Federal Register Volume 71, Number 14 (Monday, January 23, 2006)]
[Notices]
[Page 3546]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-716]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on July 12, 2005, National
Center for Natural Products Research--NIDA MProject, University of
Mississippi, 135 Coy Waller Lab Complex, University, Mississippi 38577,
made application by renewal to the Drug Enforcement Administration
(DEA) to be registered as a bulk manufacturer of the basic classes of
controlled substances listed in Schedules I:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
------------------------------------------------------------------------
The company plans to cultivate marihuana for the National Institute
of Drug Abuse for research approved by the Department of Health and
Human Services.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than March 24, 2006.
Dated: January 11, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-716 Filed 1-20-06; 8:45 am]
BILLING CODE 4410-09-P
